Clinical Trial Update: Pharmacokinetics of Empagliflozin (BI 10773) in Patients With Impaired Liver Function [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study examined empagliflozin in individuals with impaired liver function to assess how hepatic impairment affects drug exposure. Resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Insufficiency

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hepatic Insufficiency, Healthy | Phase 1 | Status: COMPLETED | Results posted: 2014-06-13